LifeMD (NASDAQ:LFMD – Get Free Report) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its peers? We will compare LifeMD to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
Analyst Ratings
This is a breakdown of current ratings for LifeMD and its peers, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LifeMD | 1 | 1 | 8 | 0 | 2.70 |
| LifeMD Competitors | 1890 | 7763 | 13430 | 841 | 2.55 |
LifeMD presently has a consensus target price of $6.71, suggesting a potential upside of 364.66%. As a group, “Healthcare Providers & Services” companies have a potential upside of 21.88%. Given LifeMD’s stronger consensus rating and higher probable upside, equities research analysts plainly believe LifeMD is more favorable than its peers.
Profitability
This table compares LifeMD and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LifeMD | -0.25% | -188.63% | -32.24% |
| LifeMD Competitors | -1.05% | -139.10% | -2.48% |
Volatility & Risk
LifeMD has a beta of 2.19, indicating that its stock price is 119% more volatile than the S&P 500. Comparatively, LifeMD’s peers have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.
Insider and Institutional Ownership
35.5% of LifeMD shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 17.2% of LifeMD shares are held by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares LifeMD and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| LifeMD | $189.24 million | $14.35 million | -24.08 |
| LifeMD Competitors | $19.22 billion | $301.67 million | -3.54 |
LifeMD’s peers have higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
LifeMD peers beat LifeMD on 7 of the 13 factors compared.
About LifeMD
LifeMD, Inc. is a virtual healthcare company that connects patients with medical providers through its telehealth platform. Its services include virtual primary care and specialty care, with offerings in areas such as men’s health and weight management. The company operates the LifeMD and Rex MD brands and supports care through online consultations, treatment plans and, when prescribed, medication. Service availability and treatment options may vary by state and individual patient needs. LifeMD serves patients in the United States.
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.
